Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001765581-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-03 | 2025-02-27 | JAZZ | Patil Neena M | EVP, CLO | A - Grant | $0.00 | +18.3K | 45.8K | +66% | $0 |
| 2025-03-03 | 2025-02-27 | JAZZ | Patil Neena M | EVP, CLO | S - Sale | $144.87 | -3,800 | 33.3K | -10% | -$550.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-02-27 | A | A | 5,778 | $0.00 | 51,614 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-02-27 | S | D | 3,800 | $144.87 | 33,318 | D | — | — | (F1) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.81 to $144.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 3 | Common | Ordinary Shares | 2025-02-27 | A | A | 12,518 | $0.00 | 45,836 | D | — | — |